✦ LIBER ✦

P-315 Dose-reduced decitabine for lower-risk myelodysplastic syndrome patients

✍ Scribed by Fang, B.; He, G.; Miao, M.; Wang, X.; Qiu, H.; Jin, Z.; Tang, X.; Han, Y.; Fu, Z.; Ma, X.; Sun, A.; Wu, D.; Ruan, C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Integrating Care for Patients With Lower

✍ Guillermo Garcia-Manero 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 688 KB

P-279 Cytogenetic response features in t

✍ Li, X.; Chang, C.K.; Oi, H.; Xu, F.; Wu, L.Y.; Su, J.Y.; Zhang, X.; Zhou, L.Y.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 65 KB

A prognostic score for patients with low

✍ Garcia-Manero, G; Shan, J; Faderl, S; Cortes, J; Ravandi, F; Borthakur, G; Wierd 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 138 KB

Quantification of outpatient management

✍ J. A. Pitako; P. S. Haas; J. Van den Bosch; H. Müller-Berndorff; A. Kündgen; U. 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 114 KB

P-289 Effect of low-dose cytarabine and

✍ Pian, S.; Duan, L.; Zhu, Y.; Hong, M.; Zhang, R.; Zhang, S.; Liu, P.; Lu, H.; Wu 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 91 KB

Cause of death in patients with lower-ri

✍ Farshid Dayyani; Anthony P. Conley; Sara S. Strom; William Stevenson; Jorge E. C 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 212 KB